What are the treatment options for a migraine attack?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Attack Treatment

For acute migraine attacks, first-line treatment should be NSAIDs (such as ibuprofen 400-600mg) for mild to moderate attacks, and triptans plus NSAIDs for moderate to severe attacks, with combination therapy providing superior relief. 1

First-Line Treatment Options

Mild to Moderate Migraine Attacks

  • NSAIDs:
    • Ibuprofen: 400-600mg
    • Naproxen sodium: 500-550mg
    • Aspirin: 800-1000mg
    • Acetaminophen: 1000mg

Moderate to Severe Migraine Attacks

  • Triptans (with or without NSAIDs):
    • Sumatriptan: 50mg orally (standard) or 6mg subcutaneously for severe attacks with significant nausea/vomiting
    • Rizatriptan: 10mg orally for patients weighing ≥40kg

Clinical trials demonstrate that sumatriptan provides significantly better pain-free response and headache relief compared to placebo, with NNTs of 4.7 for pain-free at two hours and 3.5 for headache relief at two hours with the 100mg dose 2. The FDA-approved studies show that 50-62% of patients achieve headache response within 2 hours with sumatriptan tablets versus 17-27% with placebo 3.

Second-Line Treatment Options

When first-line treatments fail or are contraindicated:

  • Antiemetics: For significant nausea/vomiting

  • CGRP Antagonists (Gepants):

    • Rimegepant
    • Ubrogepant
    • Zavegepant
  • Ditans:

    • Lasmiditan (especially when triptans are contraindicated due to cardiovascular concerns)

Treatment Algorithm

  1. Assess migraine severity:

    • Mild to moderate: Start with NSAIDs
    • Moderate to severe: Use triptans + NSAIDs
  2. If inadequate response to NSAIDs:

    • Add or switch to a triptan
    • Initiate treatment as early as possible in the attack
  3. If inadequate response to triptans or contraindications exist:

    • Try CGRP antagonists (gepants) or ditans
  4. For significant nausea/vomiting:

    • Add an antiemetic
    • Consider non-oral routes (subcutaneous sumatriptan 6mg)

Important Considerations

  • Timing: Initiate treatment as soon as possible after headache onset for best results 1

  • Medication overuse: Limit use of triptans to no more than 9 days per month and NSAIDs to no more than 15 days per month to prevent medication overuse headache 1

  • Contraindications: Triptans are contraindicated in patients with:

    • Coronary artery disease
    • Prinzmetal's variant angina
    • History of stroke or TIA
    • Uncontrolled hypertension
    • Wolff-Parkinson-White syndrome 3
  • Monitoring: Track headache frequency, severity, duration, disability, response to treatment, and adverse effects using a headache diary 1

Adverse Effects

  • Sumatriptan: Sensations of tightness, pain, pressure in chest/throat/neck/jaw (usually non-cardiac), elevated blood pressure, and serotonin syndrome (especially when combined with SSRIs/SNRIs) 3
  • NSAIDs: Gastrointestinal issues, renal effects with prolonged use

Medications to Avoid

  • Opioids and butalbital-containing medications: Not recommended for migraine treatment due to risk of medication overuse headache and worsening sleep 1, 4

Non-Pharmacological Approaches

  • Regular aerobic exercise or strength training (2-3 times/week for 30-60 minutes)
  • Trigger identification and avoidance
  • Maintaining regular sleep schedule
  • Adequate hydration
  • Relaxation techniques or mindfulness 1

By following this treatment approach and considering individual contraindications, most migraine attacks can be effectively managed with reduced disability and improved quality of life.

References

Guideline

Headache Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sumatriptan (oral route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews, 2012

Research

Acute Migraine Headache: Treatment Strategies.

American family physician, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.